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Dear Editor,
Hereditary spastic paraplegia (HSP) is a heterogeneous group of rare neurodegenerative 
diseases that are characterized by progressive weakness and spasticity of the lower limbs. 
Spastic paraplegia 10 (SPG10) is a autosomal dominant HSP with early onset that is caused 
by pathogenic variants of the kinesin family member 5A gene (KIF5A) that encodes the ki-
nesin heavy chain (KHC).1 Here we report two SPG10 patients carrying a pathogenic mis-
sense variant (c.611G>A, p.Arg204Gln), which is a novel variation that has not been report-
ed previously in Korea.
The proband was a 48-year-old man who presented with leg weakness and gait distur-
bance manifesting as tip-toe walking that had slowly progressed over 18 years. Nerve con-
duction studies (NCS) were performed to evaluate his symptoms at the age of 36 years, 
which produced no remarkable findings. Urinary dysfunction that developed in his mid-
40s was the only concomitant clinical symptom upon presentation at our center. Neuro-
logic examination revealed muscle weakness, spasticity, and brisk deep tendon reflexes in 
both legs without sensory symptoms or ataxia. Although he did not show relevant symp-
toms, NCS revealed axonal sensorimotor polyneuropathy (i.e., subclinical polyneuropa-
thy) (Supplementary Table 1 in the online-only Data Supplement). His electromyography 
and spinal cord MRI findings were normal. 
Targeted next-generation sequencing was performed for 172 genes related to neuromus-
cular disorders (1023.4x average depth with 99.9% of >30x coverage rate), which revealed 
9 rare variants (<5% minor allele frequency). A heterozygous pathogenic variant of KIF5A 
(RefSeq NM_004984.4, c.611G>A; p.R204Q, rs387907287) was identified, and further con-
firmed by Sanger sequencing, while the other eight variants were classified as variants of 
unknown significance.
A segregation study was applied to the proband’s parents and his 14-year-old son, who 
had experienced clumsy gait since the age of 8 years without other clinical manifestations, 
and who was found to carry the same heterozygous pathogenic variant (Fig. 1). 
Recent advances in genetic analyses have led to increasing reports of HSP caused by patho-
genic variants of KIF5A. Most previously reported HSP patients related to pathogenic vari-
ant c.611G>A have been childhood- or juvenile-onset cases presenting with complex HSP 
manifestations such as overt sensory symptoms or cognitive dysfunction.2-4 However, Goizet 
et al.5 reported three patients with adult-onset HSP carrying pathogenic variant c.611G>A 
in KIF5A, suggesting that not all c.611G>A variants are childhood- or juvenile-onset cases. 
Our proband lend support to this report, since he developed symptoms at the age of 30 year, 
while his son had childhood-onset HSP. We therefore surmise that this variant shows a high-
ly variable age at onset rather than having a preferential age range, implying that a long-term 
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Fig. 1. Family pedigree and sequencing chromatogram analysis. (A) 
Family pedigree of hereditary spastic paraplegia (HSP) with patho-
genic variant of the kinesin family member 5A (KIF5A) gene. The 
pedigree indicates an autosomal dominant inheritance pattern (ar-
row indicates the proband). Both the proband and his son presented 
with clinical manifestations of HSP, but with differences in their on-
set ages (30 years vs. 8 years) and disease severities. Confirmatory 
sequencing chromatograms of the heterozygous missense variant in 
KIF5A (c.611G>A, p.Arg204Gln) of the proband (B) and his son (C). 
Arrows indicate sites of the pathogenic variant.
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follow-up period is required when investigating SPG10 families 
since some of the members may develop symptoms belatedly. 
The axonal sensorimotor polyneuropathy (albeit subclin-
ical) observed in our proband has great clinical implications. 
There is accumulating evidence that KIF5A mutations con-
tribute to the pathogenesis of various neurological disorders, 
such as HSP2-5 and axonal Charcot-Marie-Tooth peripheral 
neuropathy type 2 (CMT2).4,6 Intriguingly, some patients ex-
hibit mixed features of distinct disease entities. For example, 
a recent study performed whole exome sequencing in Kore-
an CMT2 families and identified a pathogenic variant p.Arg-
204Trp in KIF5A that exhibited mixed features suggestive 
of both CMT2 and HSP.6 These findings are intriguing in 
that mutation of a single gene (KIF5A) could result in distinct 
neurological disorders that exhibit distinct selective vulner-
abilities: peripheral nerves in CMT2 and corticospinal tract 
in HSP.4,6 Given that the KHC proteins play a central role in 
the microtubule-dependent anterograde axonal transport 
of neurofilaments, pathogenic variants in KIF5A might con-
tribute to the pathogenesis of neuron degeneration,1,6 there-
by producing a wide phenotypic spectrum. This means that 
the sensorimotor polyneuropathy accompanied in our pro-
band may be at least partly explained by the weak genotype-
phenotype correlation of KIF5A variants.4,6 
We have reported the first Korean SPG10 patient carrying 
the pathogenic variant c.611G>A with an onset age of 30 years 
who exhibited generally mild neurological manifestations 
with subclinical sensorimotor polyneuropathy, mimicking 
“pure” HSP based on clinical symptoms. Genomic sequenc-
ing including that of KIF5A should be considered for HSP 
patients with or without other neurological features.
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